Omixon Welcomes Afshan Ali as Sales Manager, EMEA

12/04/2017

We are happy to announce that Afshan Ali has joined the team at Omixon’s global headquarters as a Sales Manager for the EMEA (Europe, Middle East and Africa). Afshan is a highly dynamic and successful Business Development Manager with extensive experience in working with Pharma, Diagnostics and Biotechnology companies...

Webinar – Automating Holotype HLA on Biomek 4000

11/04/2017

Join us for our upcoming Webinar to explore more about the automation of Holotype HLA on the Beckman Coulter Biomek 4000. Our special guest speaker will be Dr. Mette Christiansen (Staff Scientist, Department of Clinical Immunology, Aarhus University Hospital). NGS has ushered in an era of increased capacity for HLA genotyping...

Omixon Hires Ellia Gomes as Field Application Scientist

31/03/2017

Omixon is pleased to announce that Ellia Gomes will join Omixon’s expanding US Operations as a new Field Application Scientist, Americas in April. Ellia brings both commercial and laboratory experience in HLA to Omixon, and we are delighted to have her join our US Team. Ellia received a BS...

ASHI Regional Symposium – Holotype HLA: A Technical Introduction to NGS Assay, Software and Automation

22/03/2017

We are pleased to announce that Omixon is sponsoring a Lunch Symposium for attendees at the upcoming ASHI Regional Education Workshop I in Mesa, AZ, USA. Please join Efi Melista (Head of Field and Lab Operations, Omixon) and Tim Hague (CEO, Omixon) for our event. Title: Holotype HLA: A Technical...

Organ-, Body-, Human-on-a-chip

21/03/2017

In February we took a short glimpse of the different scientific techniques that are used to create replacement organs. It goes without saying that all of the mentioned ones, 3D bioprinting, Xenotransplantation, stem cell research are fantastic and unique – but for drug discovery research, we have to add...